Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily...

by Plate T, Friedrich FW, Beier J
Published 2020-06-01

Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype – a post-hoc analysis of a randomized, double-blind, placebo-controlled...

by Beeh KM, Beier J, Candler H, Wittig T
Published 2016-11-01

Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase III...

by Beier J, Mroz R, Kirsten AM, Chuecos F, Garcia Gil E
Published 2017-06-01

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD...

by Brooks J, Deans A, Beier J, van Noord J, Cahn A, Mehta R, Baggen S, Maden C
Published 2012-03-01

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-...

by Beeh KM, Kirsten AM, Tanase AM, Richard A, Cao W, Hederer B, Beier J, Kornmann O, van Zyl-Smit RN
Published 2018-12-01